CHRNB3 c.-57A>G functional promoter change affects Parkinson's disease and smoking

Anat Bar-Shira, Mali Gana-Weisz, Ziv Gan-Or, Eytan Giladi, Nir Giladi, Avi Orr-Urtreger*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review


Cigarette smoking is protective in Parkinson's disease (PD), possibly because of nicotine action on brain nicotinic-acetylcholine receptors. The β3 nicotinic-acetylcholine receptor subunit (encoded by CHRNB3) is depleted in the striatum of PD patients and associated with nicotine dependence. Herein, the CHRNB3 gene was sequenced, and the c.-57G allele frequency was 0.31 and 0.26 among patients (n= 596) and controls (n= 369), respectively (p= 0.02, odds ratio= 1.33, 95% confidence interval= 1.03-1.73). The c.-57G allele was strongly associated with smoking in patients, as 48.4% of c.-57G carriers compared with 32.6% of noncarriers reported smoking history (p < 0.0001). The transcription factor Oct-1 binding was almost eliminated in lymphoblasts with the c.-57G/G genotype, to only 6.5% percent, and the CHRNB3 promoter activity was reduced in cells with the c.-57G/G genotype by 96%-70%. These findings suggest that the CHRNB3 c.-57A>G alteration affects the promoter activity and is associated with PD and smoking in PD patients. It is therefore possible that nicotine may be valuable for patients who carry this alteration and beneficial in PD only for patients with specific genotypes.

Original languageEnglish
Pages (from-to)2179.e1-2179.e6
JournalNeurobiology of Aging
Issue number9
StatePublished - Sep 2014


  • CHRNB3
  • Genetics
  • Parkinson's disease
  • Smoking
  • β3 nicotinic-acetylcholine receptor subunit


Dive into the research topics of 'CHRNB3 c.-57A>G functional promoter change affects Parkinson's disease and smoking'. Together they form a unique fingerprint.

Cite this